Moneycontrol
Last Updated : Mar 12, 2019 10:12 AM IST | Source: Moneycontrol.com

Laurus Labs jumps 2% on USFDA approval for malaria drug

The US Food and Drug Administration (FDA) has given its approval for Laurus Labs' Hydroxychloroquine tablets in the strength of 200 mg.

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shares of Laurus Labs rose as much as 2.2 percent in early trade after receiving FDA approval for its drug used in treatment of malaria and certain autoimmune diseases.

The US Food and Drug Administration (FDA) has given its approval for Laurus Labs' Hydroxychloroquine tablets in the strength of 200 mg.

"The Company also received a tentative approval for an ANDA for Abacavir, Dolutegravir, and Lamivudine, Tablets 600 mg/50 mg/300 mg from USFDA." Laurus Labd said in a statement.

The products will be commercialized from the company's manufacturing facility at Atchutapuram, Visakhapatnam.

At 09:25 hrs, Laurus Labs was quoting at Rs 367.9 on the BSE, up 1.11 percent.
First Published on Mar 12, 2019 10:12 am
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant